↓ Skip to main content

Dove Medical Press

Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia

Overview of attention for article published in Infection and Drug Resistance, May 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
28 Mendeley
Title
Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia
Published in
Infection and Drug Resistance, May 2014
DOI 10.2147/idr.s25930
Pubmed ID
Authors

Ethan Rubinstein, Martin E Stryjewski, Steven L Barriere

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 14%
Unspecified 3 11%
Student > Doctoral Student 3 11%
Student > Bachelor 3 11%
Student > Master 3 11%
Other 4 14%
Unknown 8 29%
Readers by discipline Count As %
Medicine and Dentistry 8 29%
Unspecified 3 11%
Pharmacology, Toxicology and Pharmaceutical Science 3 11%
Agricultural and Biological Sciences 2 7%
Chemical Engineering 1 4%
Other 1 4%
Unknown 10 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 September 2019.
All research outputs
#7,597,150
of 23,164,913 outputs
Outputs from Infection and Drug Resistance
#297
of 1,706 outputs
Outputs of similar age
#74,984
of 228,790 outputs
Outputs of similar age from Infection and Drug Resistance
#8
of 9 outputs
Altmetric has tracked 23,164,913 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,706 research outputs from this source. They receive a mean Attention Score of 3.9. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,790 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one.